Alex CheesmanMay 15, 2024
The Challenge mdgroup supported a groundbreaking initiative in paediatric clinical trials, focusing on children with SCN2A-DEE and SCN8A-DEE, which causes a range of neurological conditions, including severe early-onset epilepsies, encephalopathies,…
Read More